Coloplast
COLO-B.CO
#649
Rank
$30.28 B
Marketcap
$134.70
Share price
0.54%
Change (1 day)
8.80%
Change (1 year)
Categories

P/E ratio for Coloplast (COLO-B.CO)

P/E ratio as of March 2024 (TTM): 42.1

According to Coloplast's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.1351. At the end of 2022 the company had a P/E ratio of 34.1.

P/E ratio history for Coloplast from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202234.1-23.2%
202144.5-13.1%
202051.214.24%
201944.821.97%
201836.728.71%
201728.5-17.57%
201634.6-67.97%
2015108152.89%
201442.775.01%
201324.44.51%
201223.421.05%
201119.3-13.68%
201022.48.7%
200920.6-14.62%
200824.1-62.28%
200763.989.26%
200633.87.14%
200531.50.35%
200431.43.98%
200330.282.03%
200216.6

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.